NEW YORK, Sept. 4 – ZymoGenetics and Serono said Tuesday that they had entered an exclusive agreement to develop treatments for autoimmune diseases in a deal that could generate up to $52.5 million in payments for ZymoGenetics.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: metagenomic-based technique for determining protein structure, and more.
An academic laments the rise of narcissism in the sciences, the Guardian reports.
Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.
The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.